Year: 2023

25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit.  ● In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from the $269,323 reported in Q3 2022.  ● Achieved a 55% gross margin over the nine months ending September 30, 2023, representing a 551-basis point growth in gross profit compared to the same period in 2022, and realized a remarkable 51% increase in gross profit, reaching $189,510 in the three months ended September 30, 2023, compared to $125,607 for the corresponding period in 2022.  ● Net operating loss for nine months ending September 30, 2023, decreased by 54% to $191,747 compared to the same period in 2022.  ● Projecting positive net income in 2024.WEST PALM BEACH, FL, Nov. 14, 2023 (GLOBE NEWSWIRE) — QHSLab, Inc. (the...

GERMANTOWN, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today announced it ranked 171 on the Deloitte Technology Fast 500™, a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year. Vered Caplan, CEO of Orgenesis, commented, “We are very proud to be recognized on the prestigious 2023 Deloitte Technology Fast 500™ list. Over the past decade, our team has worked to engineer a decentralized approach to manufacturing advanced cell and gene therapies, which lowers costs, streamlines logistics, and expands capacity. We are rapidly gaining traction in the market and remain...

Quarterly Revenue Increased 11% Revenue from Small Business Administration Transactions Doubled Quarterly Revenue Per Transaction Increased 78% BOCA RATON, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) —  Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled B2B fintech marketplace connecting commercial property borrowers and lenders with a human touch, today provided a business update, and announced its financial results for the third quarter ended September 30, 2023. Financial Highlights11% year-over-year revenue growth for the quarter ended September 30, 2023; 16% improvement in adjusted EBITDA for the 9 months ended September 30, 2023; Revenue per transaction increased 78% year-over-year for the third quarter of 2023; and Completed an IPO on July 25, 2023 onto the Nasdaq Stock Market raising over $5.0 million, with...

Mudra Band’s Gesture Algorithm Focusing on Finger Movement Exceled in 1,000-User Test, Ready for Widespread Mobile OS Deployment YOKNEAM ILLIT, ISRAEL, Nov. 14, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a pioneering tech firm specializing in AI-powered touchless sensing wearables, today announced that its gesture recognition algorithm has passed accuracy performance testing on a carefully curated custom dataset for finger movement recognition based on first-time usage. The AI-based system is designed to produce models that address the three essential user experience requirements of accuracy, false positive recognition, and responsiveness. The algorithm is universally compatible with the leading mobile operating systems. This includes support for TensorFlow...

Research conducted by Vertex shows tax professionals are feeling personally exposed by the shocking levels of risk tolerance of their employers. LONDON, Nov. 14, 2023 (GLOBE NEWSWIRE) —  According to research conducted by Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, the approach to indirect tax compliance by almost three quarters of global businesses is risk prone. Seventy-four percent of global businesses report accepting indirect tax compliance risks, in relation to their company’s tax compliance strategy. Peter Boerhof, Senior Director of VAT for Vertex’s Chief Tax Office, commented on the findings: “The attitude to indirect tax compliance by businesses everywhere is concerning, particularly when the technology exists to mitigate many risks being taken. If businesses...

Stronghold to Hold Analyst and Investor Day on December 12, 2023 NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, the “Company”, or “we”) today announced the following: Recent Operational and Financial HighlightsStronghold’s Beneficial Use Ash Can Capture Carbon Dioxide (CO2). Following four months of extensive testing, third-party lab results indicate that Stronghold’s beneficial use ash, a natural byproduct of its mining-waste-to-power process, can capture CO2 from ambient air at a capacity of up to 12% by weight of starting ash. The process results in permanent and stable storage of the CO2. Initial Phase of Carbon Capture Project Underway at the Scrubgrass Plant. Stronghold and third-party engineering, design, and construction partners have developed direct air capture...

TransUnion quarterly report finds compulsory bundling with increased cyber coverage a promising strategy CHICAGO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Macroeconomic trends affecting insurance shopping in the first half of 2023 continued throughout Q3. Auto and property insurance shopping rates were flat compared to Q2 2023 but elevated 12% and 6%, respectively, compared to Q3 2022. The findings are part of TransUnion’s (NYSE: TRU) latest quarterly Insurance Personal Lines Trends and Perspectives Report, which includes trends in the auto and property insurance markets, as well as survey data about consumers’ behaviors and attitudes. The search for lower insurance premiums remains a primary driver of auto insurance shopping. The Insurance Information Institute forecasted auto insurance premium growth of 10.4% in 2023—double the 5% premium...

Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins Today at 10:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immuno-oncology therapies and next-generation vaccines, today announced financial results for the three and nine months ended September 30, 2023. The Company also provided an update on its clinical development programs with IMNN-001 (formerly GEN-1), a DNA-based interleukin-12 (IL-12) immunotherapy in Phase 2 clinical development for the treatment of first-line locally advanced ovarian cancer; on its PlaCCine modality, a proprietary mono- or multi-cistronic...